Respiratory syncytial virus is the leading cause of hospitalization among U.S. infants. A vaccine, nirsevimab, can reduce the ...

As the post-holiday viruses spread around the country, health experts are warning of a ‘quad-demic’ of illnesses that could ...

Flu cases are surging across the commonwealth but for the youngest Pennsylvanians, another potentially dangerous respiratory ...

A 6-year-old boy has RSV, strep throat, and pneumonia. His mother never thought a cough could escalate so fast.

Influenza concentrations started to rise in November, and have continued to rise through December. RSV, or respiratory ...

RSV and the flu have taken hold as Chicago residents have partaken in festivities in the last several weeks, and COVID is ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, ...

The adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...

Common RSV symptoms include coughing, congestion, and headaches, as well as trouble eating, drinking, and swallowing. RSV ...

RSV is "a common respiratory virus that infects the nose, throat, and lungs. RSV symptoms make it difficult to distinguish it ...

The RSVPreF vaccine is safe and demonstrates immunobridging to efficacy among adults aged 18 to 59 who are at high risk for ...

Vaccines to protect against respiratory syncytial virus (RSV) in newborns and older adults are being more widely accepted by ...